During this process, drug-resistant stem/progenitor-like epithelial populations can stimulate myCAFs to produce CCL2 via soluble mediators (e.g., TNF), thereby recruiting CCR2+ tumor-associated macrophages (TAMs). The gene discussed is CCL2; the disease is neoplasm.